Clinical Trial: Prenatal Test for Fetal Aneuploidy Detection

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Investigational Study of a Prenatal Diagnostic Test for Fetal Aneuploidy

Brief Summary: The purpose of this study is to develop and evaluate a blood test for pregnant women for detection of fetal aneuploidy.

Detailed Summary:
Sponsor: Roche Sequencing Solutions

Current Primary Outcome: Comparison of blood test to results from chorionic villus sampling or amniocentesis for fetal aneuploidy detection [ Time Frame: 24 months ]

Circulating genomic material from maternal blood will be quantified using biochemical techniques to determine the presence of fetal aneuploidy. The results obtained from analysis of circulating genomic material will be compared to the karyotype results from chorionic villus sampling or amniocentesis.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Roche Sequencing Solutions

Dates:
Date Received: November 22, 2010
Date Started: August 2010
Date Completion:
Last Updated: January 8, 2013
Last Verified: January 2013